Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1248-2025Class II

ASP BIOTRACE Auto Read 60 Steam BI Process Challenge Device, REF 73135

Terragene LLC / initiated 2025-01-15 / Open, Classified / root cause: labeling and UDI

TERRAGENE S.A. began a recall of ASP BIOTRACE Auto Read 60 Steam BI Process Challenge Device, REF 73135 on . FDA classified it as Class II and gives the reason as "Error in the IFU lists an incorrect incubation time on one occasion of 20 minutes rather than the correct incubation time of 60 minutes". As of , the recall status on record is Open, Classified, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-1248-2025
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Terragene LLC
Product
ASP BIOTRACE Auto Read 60 Steam BI Process Challenge Device, REF 73135.
Product code
FRC Indicator, Biological Sterilization Process
Reason for recall
Error in the IFU lists an incorrect incubation time on one occasion of 20 minutes rather than the correct incubation time of 60 minutes.
Root cause tag
labeling and UDI
FDA root cause
Labeling False and Misleading
Action
The recalling firm issued an email on 1/15/2025 to the main office of the distributor with an attached Distributor Customer Communication letter dated 1/15/2025, an Acknowledgement and Receipt Form, an updated IFU (Rev.B R01), and a User Letter for the distributor to issue to their customers. The letter to the distributor explains that all product is affected that contains version Rev.A R0 of the IFU because a discrepancy was identified in that version. The Distributor is to review their inventory records for the affected product, identify customers that received or may have received the devices and report it to the recalling firm through the provided Acknowledgement and Receipt Form via email. The Distributor is informed the product can be used according to the enclosed updated IFU (Rev.B R01). The Distributor was requested to notify their customer by using the enclosed User Letter and include the updated IFU with the User Letter. The Distributor is also informed they can continue distribution of their inventory by sending the digital user letter and the updated digital IFU with each delivery. An updated printed IFU will also be made available to users upon request. The User Letter was similar to the Distributor letter except that it instructs the user to discard older version of the IFU (Rev.A R0 and use the product according to the IFU attached to the letter and available on the firm's website. an Acknowledgement and Receipt Form was also enclosed for completion and return.
Quantity in commerce
914 devices in the U.S.
Distribution
US Nationwide distribution in the states of CA and KY.
Product codes and lots
Lot numbers: F40062, F40064, F40072, F40074, F40101, F40116; UDI-DI - 07798375772624 (primary packaging), 07798375772877 (secondary packaging) containing IFU Rev.A R0.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1248-2025
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1248-2025Class IIOngoingVoluntary: Firm initiated